For prostate cancer imaging, Na+-coupled neutral amino acid transporter SNAT2 and another neutral amino acid transporter ASCT2 as well as Na+-independent l-amino acid transporter LAT1 are all upregulated. This evidence concerns the gene SLC1A5 and prostate carcinoma.